These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7118558)

  • 41. Urinary pH and stone formation.
    Wagner CA; Mohebbi N
    J Nephrol; 2010; 23 Suppl 16():S165-9. PubMed ID: 21170875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 24-h uric acid excretion and the risk of kidney stones.
    Curhan GC; Taylor EN
    Kidney Int; 2008 Feb; 73(4):489-96. PubMed ID: 18059457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct titrimetric determination of uric acid separately and in urine of patients containing stone.
    Shyam H; Saxena OC
    Ital J Biochem; 1973; 22(2):65-73. PubMed ID: 4771416
    [No Abstract]   [Full Text] [Related]  

  • 44. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria.
    Sidhu H; Hoppe B; Hesse A; Tenbrock K; Brömme S; Rietschel E; Peck AB
    Lancet; 1998 Sep; 352(9133):1026-9. PubMed ID: 9759746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis?
    Hoppe B; Hesse A; Brömme S; Rietschel E; Michalk D
    Pediatr Nephrol; 1998 May; 12(4):275-9. PubMed ID: 9655356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal calculi and their management.
    Melick RA
    Med J Aust; 1976 Mar; 1(10):308-10. PubMed ID: 1272102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Juvenile renal stone disease: a study of urinary promoting and inhibiting factors.
    Baggio B; Gambaro G; Favaro S; Borsatti A; Pavanello L; Siviero B; Zacchello G; Rizzoni GF
    J Urol; 1983 Dec; 130(6):1133-5. PubMed ID: 6315967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperuricosuria in cystic fibrosis patients treated with pancreatic enzyme supplements. A study of 16 patients in Israel.
    Sack J; Blau H; Goldfarb D; Ben-Zaray S; Katznelson D
    Isr J Med Sci; 1980 Jun; 16(6):417-9. PubMed ID: 6901713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Calcium lithiasis: uric acid under question].
    Petit C
    Nephrologie; 1984; 5(5):192-4. PubMed ID: 6531055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possible role of carbohydrate-induced calciuria in calcium oxalate kidney-stone formation.
    Lemann J; Piering WF; Lennon EJ
    N Engl J Med; 1969 Jan; 280(5):232-7. PubMed ID: 5818178
    [No Abstract]   [Full Text] [Related]  

  • 53. [Modification of the risk of urolithiasis by changes in magnesium and calcium concentrations in the urine as affected by stress conditions].
    Brundig P; Börner RH; Schulz E; Pirlich W
    Z Urol Nephrol; 1985 May; 78(5):245-51. PubMed ID: 4036378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of urinary parameters as risk factors for nephrolithiasis in children with celiac disease.
    Saccomani MD; Pizzini C; Piacentini GL; Boner AL; Peroni DG
    J Urol; 2012 Aug; 188(2):566-70. PubMed ID: 22704115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kidney stones.
    Kleeman CR; Coburn JW; Brickman AS; Lee DB; Narins RG; Ehrlich RM
    West J Med; 1980 Apr; 132(4):313-32. PubMed ID: 7385835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between the severity of renal stone disease and urine composition.
    Tiselius HG
    Eur Urol; 1979; 5(5):323-7. PubMed ID: 446508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Allopurinol induced electrolyte and metabolism changes in the urine of patients with kidney stones].
    Schwille PO; Jügelt U; Sigel A
    Urologe A; 1972 Jul; 11(4):185-9. PubMed ID: 5071601
    [No Abstract]   [Full Text] [Related]  

  • 58. Tubular defects in patients forming calcium-containing stones.
    Backman U
    Eur Urol; 1978; 4(1):50-6. PubMed ID: 342251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dyslipidaemia in overweight children and adolescents is associated with an increased risk of kidney stones.
    Kirejczyk JK; Korzeniecka-Kozerska A; Baran M; Porowska H; Porowski T; Wasilewska A
    Acta Paediatr; 2015 Sep; 104(9):e407-13. PubMed ID: 26096629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Which factors account for renal stone formation in cystic fibrosis?
    von der Heiden R; Balestra AP; Bianchetti MG; Casaulta Aebischer C; Mullis PE; Lippuner K; Jaeger P
    Clin Nephrol; 2003 Mar; 59(3):160-3. PubMed ID: 12653257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.